CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Belgium

2018-04-01
Price :
Published : Apr-2018
No. of Pages : 131

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Belgium

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Belgium”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Belgium. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Belgium. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Belgium is one of the largest healthcare markets, with a strong focus on pharmaceutical exports. It spends approximately 10.4% of its GDP on healthcare. The value of the Belgian pharmaceutical market declined from $7.8 billion in 2009 to $6.9 billion in 2016, at a negative compound annual growth rate (CAGR) of 2%. However, the value of the pharmaceutical market in terms of Euros increased from €5.8 billion to €6.2 billion at a CAGR of 1%. This difference was due to the declining exchange rate of the Euro versus the US Dollar. The Belgian medical device market was valued at $2.16 billion in 2010, which increased to $2.68 billion in 2017. The main segments were cardiovascular devices, ophthalmic devices, orthopedic devices, in vitro diagnostics and hospital supplies. The increasing elderly population and high investment in R&D expenditure are expected to drive the growth of the pharmaceutical market. However, generic substitution and high taxes act as a major barrier for the pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Belgium, and includes –
– An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
– Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Sanofi, Leo Pharma, UCB Pharma and Ablynx) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Essilor, Zimmer Biomet, AGFA and IBA)
– Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Belgium
– Porter’s five forces analysis for pharmaceutical and medical devices market of Belgium
– An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
– Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
– An overview of the opportunities for and challenges to growth in the Belgian healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to –
– Develop business strategies by understanding the trends shaping and driving the Belgian healthcare market
– Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
– Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
– Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
– Identify, understand, and capitalize on the opportunities and challenges in the Belgian healthcare market.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Digital Landscape: Breast Cancer

Digital Landscape: Breast Cancer Summary The "Digital Landscape: Breast Cancer", report analyzes digital activities undertaken by pharma in support of therapies for breast cancer. Key Highlights - US Patients: Strong digital support for US breast cancer patients in the US, particularly from Pfizer, Novartis and AstraZeneca. Most recent branded activity seen from Lilly and Novartis in the CDK4/6 inhibitor space. Most unbranded and social media activity focuses on supporting patients with metastatic breast cancer. Few breast cancer-specific mobile apps detected in the US. - US HCPs: There is little support for HCPs in the breast cancer space beyond branded. AstraZeneca, Genentech, Novartis and Pfizer offer examples of strong branded resources. The pharma-sponsored unbranded and ......
$6000

Digital Landscape: Inflammatory Bowel Disease

Digital Landscape: Inflammatory Bowel Disease Summary The Digital Landscape Inflammatory Bowel Disease report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn's disease and ulcerative colitis (UC). Key Highlights - US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen was the most active competitor in the branded and social media spaces in 2017. Branded activity also seen from pipeline and biosimilar competitors. No IBD-specific mobile apps detected from pharma. Opportunity exists for a well-integrated unbranded campaign to support patients, linked to social media and a mobile app. - US HCPs: Good support av......
$6000

PharmSource – Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook – 2018 Edition

PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook - 2018 Edition Summary The motivation for pharma companies outsourcing their manufacturing is often to do with lacking expertise, equipment, or cost reduction (especially for small to mid-sized CMOs) in development of their product's API or dose. For clinical dose manufacturing, there is a high risk associated with the pipeline drug product and as such using a CMO for this mitigates risk for pharma companies that may otherwise have to invest in equipment and facilities. This report, the 2018 version in this annual series, characterizes the contract dose manufacturing industry along a number of quantitative dimensions, including number and type of participants, market size, m......
$4995

Healthcare Industry Business Outlook and Procurement Report July 2018 – December 2018

Healthcare Industry Business Outlook and Procurement Report July 2018 - December 2018 Summary GlobalData's "Healthcare Industry Business Outlook and Procurement Report July 2018 - December 2018", examines executives' opinions on the business outlook and procurement activities over July-December 2018. Organizations can know about key business priorities, changes in capital expenditure, global revenue contributors, and key information about the organizations' digital transformation strategies along with investment in emerging technologies. Additionally, it provides information categorized by region and company types. The highest percentages of healthcare industry executives identify expansion in the current market and new product development as the foremost priorities of healthcare ......
$1950

House Dust Mite Allergy Global Clinical Trials Review, H2, 2018

House Dust Mite Allergy Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "House Dust Mite Allergy Global Clinical Trials Review, H2, 2018" provides an overview of House Dust Mite Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on House Dust Mite Allergy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Phar......
$2500

Kidney Transplant Rejection Global Clinical Trials Review, H2, 2018

Kidney Transplant Rejection Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Kidney Transplant Rejection Global Clinical Trials Review, H2, 2018" provides an overview of Kidney Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical trials on Kidney Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary......
$2500

Amyotrophic Lateral Sclerosis: Epidemiology Forecast to 2027

Amyotrophic Lateral Sclerosis: Epidemiology Forecast to 2027 Summary ALS is a rare but fatal progressive neurodegenerative disease that affects the nerve cells in the brain and the spinal cord (Doi et al., 2014). ALS is often referred to as "Lou Gehrig's Disease" after the famous baseball player. ALS severely impacts physical functioning, and initially presents with muscle twitching, weakness in an arm or leg, or sometimes with slurring of speech. Eventually, people with ALS lose their ability to control the muscles needed to move, speak, eat, and breathe, which ultimately leads to death. GlobalData epidemiologists used age- and sex-specific diagnosed prevalence rates to forecast the diagnosed prevalent cases, and used the diagnosis rate and diagnosed prevalence to calculate total......
$3995

Immunochemistry Analyzers – Medical Devices Pipeline Assessment, 2018

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2018" provides an overview of Immunochemistry Analyzers currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunochemistry Analyzers pipeline products. This report is prepared using data sourced from in-house databases, secondary and......
$4000

Alzheimer Diagnostic Tests – Medical Devices Pipeline Assessment, 2018

Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Alzheimer Diagnostic Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary......
$4000

Colorectal Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2018

Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018 Summary GlobalData's Medical Devices sector report, "Colorectal Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2018" provides an overview of Colorectal Cancer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Colorectal Cancer Diagnostic Tests pipeline products. This report is prepared using data sourced fr......
$4000
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy